(Q42997617)

12 November 2017

title

Characteristics of hepatitis C viral genome associated with disease progression (English)

1 reference

12 November 2017

Nagayama K

1

1 reference

12 November 2017

Kurosaki M

2

1 reference

12 November 2017

Enomoto N

3

1 reference

12 November 2017

Miyasaka Y

4

1 reference

12 November 2017

Marumo F

5

1 reference

12 November 2017

Sato C

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

12 November 2017

1 reference

12 November 2017

volume

31

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

745-750

1 reference

The molecular basis of virulence of the encephalitogenic flaviviruses

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

The molecular virology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Persistent hepatitis C viraemia without liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Long-term observation of HCV-positive patients with normal ALT values: persistence of a clinically healthy state

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

A proposed system for the nomenclature of hepatitis C viral genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

A second hepatitis C virus-encoded proteinase

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310327

7 January 2021

Identifiers

DOI

10.1002/HEP.510310327

1 reference

12 November 2017

1 reference